Stratos Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Buy
24,374
+103
+0.4% +$11.9K 0.18% 119
2025
Q4
$2.55M Buy
24,271
+699
+3% +$65.6K 0.12% 185
2025
Q3
$1.98M Buy
23,572
+3,252
+16% +$268K 0.1% 218
2025
Q2
$1.61M Sell
20,320
-1,454
-7% -$116K 0.08% 246
2025
Q1
$1.95M Sell
21,774
-17,730
-45% -$1.66M 0.11% 187
2024
Q4
$3.93M Buy
39,504
+814
+2% +$83.9K 0.19% 120
2024
Q3
$4.39M Buy
38,690
+14,713
+61% +$1.75M 0.2% 111
2024
Q2
$2.97M Buy
23,977
+1,366
+6% +$176K 0.15% 151
2024
Q1
$2.98M Sell
22,611
-39,143
-63% -$4.82M 0.18% 138
2023
Q4
$6.73M Buy
61,754
+2,216
+4% +$230K 0.39% 59
2023
Q3
$6.13M Buy
59,538
+9,903
+20% +$1.07M 0.4% 59
2023
Q2
$5.73M Buy
49,635
+375
+0.8% +$42.6K 0.41% 62
2023
Q1
$5.24M Buy
49,260
+512
+1% +$55.3K 0.4% 62
2022
Q4
$5.41M Buy
48,748
+574
+1% +$58.7K 0.45% 49
2022
Q3
$4.15M Sell
48,174
-1,385
-3% -$124K 0.44% 58
2022
Q2
$4.52M Sell
49,559
-1,722
-3% -$153K 0.41% 61
2022
Q1
$4.21M Buy
51,281
+1,269
+3% +$100K 0.34% 78
2021
Q4
$3.83M Buy
50,012
+1,609
+3% +$128K 0.28% 101
2021
Q3
$3.64M Sell
48,403
-1,554
-3% -$118K 0.31% 84
2021
Q2
$3.88M Buy
49,957
+3,210
+7% +$239K 0.34% 78
2021
Q1
$3.44M Buy
46,747
+6,397
+16% +$472K 0.37% 76
2020
Q4
$3.15M Buy
40,350
+7,900
+24% +$604K 0.43% 61
2020
Q3
$2.57M Buy
32,450
+548
+2% +$42.9K 0.63% 43
2020
Q2
$2.35M Buy
31,902
+24,152
+312% +$1.82M 0.72% 40
2020
Q1
$569K Sell
7,750
-308
-4% -$24.2K 0.4% 66
2019
Q4
$699K Sell
8,058
-8,114
-50% -$666K 0.4% 61
2019
Q3
$1.3M Buy
16,172
+299
+2% +$24K 0.5% 52
2019
Q2
$1.27M Buy
15,873
+543
+4% +$41.6K 0.51% 48
2019
Q1
$1.22M Buy
15,330
+2,307
+18% +$173K 0.66% 37
2018
Q4
$950K Buy
+13,023
New +$919K 0.63% 44

Other funds holding MRK

Stratos Wealth Advisors's MRK Position: Q1 2026 in Review

Stratos Wealth Advisors increased its Merck (MRK) stake by 0.42% in Q1 2026, buying an estimated $11.9K and bringing the position to 24,374 shares worth $2.93M. The position accounts for 0.18% of the portfolio, ranked #119.

Stratos Wealth Advisors first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.73M in Q4 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Stratos Wealth Advisors held 24,374 shares of Merck worth $2.93M as of Q1 2026.
  • Stratos Wealth Advisors bought 103 Merck shares in Q1 2026, an estimated $11.9K.
  • Merck made up 0.18% of Stratos Wealth Advisors's portfolio in Q1 2026, its #119 holding.
  • Stratos Wealth Advisors first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Stratos Wealth Advisors's Merck position peaked at $6.73M in Q4 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.